Northrop Grumman (NOC) Q2 2025 Financial Results Summary

0
32

# Northrop Grumman Corporation (NOC) Q2 2025 Financial Results Summary

**Release Date: July 22, 2025**

Northrop Grumman Corporation (NYSE: NOC) reported its financial results for Q2 2025, indicating a positive performance across several key metrics. Here are the highlights:

### Sales and Revenue
– **Total Sales:** Increased by **1%** to **$10.4 billion** compared to **$10.2 billion** in Q2 2024.
– **Segment Sales Growth:**
– **Aeronautics Systems:** Up **2%** to **$3.1 billion**.
– **Defense Systems:** Increased **7%** to **$1.99 billion**.
– **Mission Systems:** Grew **14%** to **$3.16 billion**.
– **Space Systems:** Decreased **12%** to **$2.65 billion**.

### Earnings
– **Net Earnings:** Rose **25%** to **$1.2 billion**, or **$8.15** per diluted share, up from **$940 million** or **$6.36** per diluted share in Q2 2024.
– **Diluted EPS:** Grew by **28%** from the prior period, largely aided by a **$1.04** per share benefit from the sale of the training services division.

### Operating Performance
– **Operating Income:** Increased **31%** to **$1.425 billion** from **$1.09 billion** in Q2 2024.
– **Operating Margin Rate:** Improved by **310 basis points** to **13.8%**, compared to **10.7%** in the prior year.
– **Segment Operating Income:** Up **11%** overall to **$1.219 billion**, with a margin rate of **11.8%**, an increase from **10.8%**.

### Cash Flow and Capital Management
– **Free Cash Flow:** Declined **42%** to **$637 million** from **$1.11 billion** in Q2 2024, primarily due to increased cash taxes.
– **Net Cash from Operating Activities:** Turned negative at **-$697 million**, a significant decrease compared to a positive **$719 million** in the same quarter last year.
– **Capital Expenditures:** Reduced by **28%** to **$231 million** from **$320 million** in Q2 2024.

### Dividends and Share Repurchases
– **Returned to Shareholders:** Over **$700 million** was returned through share repurchases and dividends in Q2 2025.
– No details were provided on the specific dividend amount per share declared during this quarter.

### International and Future Outlook
– **International Sales Growth:** Increased by **18%** in the quarter, underscoring robust demand for Northrop Grumman’s offerings.
– **Revised 2025 Guidance:**
– **Sales:** Expected in the range of **$42.05 – $42.25 billion**.
– **Segment Operating Income:** Forecasted to be **$4,275 – $4,375 million**.
– **MTM-adjusted EPS:** Forecasted to range between **$25.00 – $25.40**.
– **Free Cash Flow:** Projected to be between **$3,050 – $3,350 million**.

### Backlog and Awards
– **Total Backlog:** Stood at **$89.7 billion**, down **2%** from **$91.5 billion** in December 2024.
– **Net Awards in Q2 2025:** Totaled **$7.4 billion**, with significant contracts in the Mission Systems, Defense Systems, and Aeronautics Systems sectors.

### Conclusion
Northrop Grumman’s Q2 2025 results reflect solid growth in sales and earnings, driven by improved operational efficiency and strategic performance across various segments, despite challenges in certain areas like space systems. The company’s commitment to returning value to shareholders and increasing guidance for key financial metrics highlights a positive outlook for the remainder of the year.

### CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS AND COMPREHENSIVE INCOME

$ in millions, except per share amounts Three Months Ended June 30 Six Months Ended June 30
Sales 2025 2024 2025 2024
Product $8,258 $8,076 $15,779 $16,178
Service 2,093 2,142 4,040 4,173
Total sales 10,351 10,218 19,819 20,351
Operating costs and expenses
Product 6,526 6,388 12,892 12,799
Service 1,615 1,639 3,137 3,228
General and administrative expenses 1,016 1,101 2,023 2,163
Total operating costs and expenses 9,157 9,128 18,052 18,190
Gain on sale of business 231 231
Operating income 1,425 1,090 1,998 2,161
Other (expense) income
Interest expense -173 -154 -329 -300
Non-operating FAS pension benefit 137 167 267 335
Other, net 38 43 69 81
Earnings before income taxes 1,427 1,146 2,005 2,277
Federal and foreign income tax expense 253 206 350 393
Net earnings $1,174 $940 $1,655 $1,884
Basic earnings per share $8.17 $6.37 $11.48 $12.72
Weighted-average common shares outstanding, in millions 143.7 147.5 144.2 148.1
Diluted earnings per share $8.15 $6.36 $11.45 $12.69
Weighted-average diluted shares outstanding, in millions 144.0 147.7 144.5 148.5
Net earnings (from above) $1,174 $940 $1,655 $1,884
Other comprehensive income (loss), net of tax
Change in cumulative translation adjustment 7 -1 9
Change in other, net 11 -2 19 -18
Other comprehensive income (loss), net of tax 18 -3 28 -18
Comprehensive income $1,192 $937 $1,683 $1,866

### CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

$ in millions, except par value June 30, 2025 December 31, 2024
Assets
Cash and cash equivalents $1,899 $4,353
Accounts receivable, net 2,196 1,272
Unbilled receivables, net 7,133 5,908
Inventoried costs, net 1,553 1,455
Prepaid expenses and other current assets 1,245 1,286
Total current assets 14,026 14,274
Property, plant and equipment, net of accumulated depreciation of $9,207 for 2025 and $8,733 for 2024 10,537 10,536
Operating lease right-of-use assets 1,783 1,770
Goodwill 17,435 17,512
Intangible assets, net 231 254
Deferred tax assets 1,713 1,599
Pension and other postretirement benefit plan assets 2,393 2,184
Other non-current assets 1,333 1,230
Total assets $49,451 $49,359
Liabilities
Trade accounts payable $2,592 $2,599
Accrued employee compensation 1,856 2,271
Advance payments and billings in excess of costs incurred 3,997 4,070
Other current liabilities 5,014 5,188
Total current liabilities 13,459 14,128
Long-term debt, net of current portion of $551 for 2025 and $1,582 for 2024 15,160 14,692
Pension and other postretirement benefit plan liabilities 1,108 1,120
Operating lease liabilities 1,805 1,798
Other non-current liabilities 2,448 2,331
Total liabilities 33,980 34,069
Shareholders’ equity
Preferred stock, $1 par value; 10,000,000 shares authorized; no shares issued and outstanding
Common stock, $1 par value; 800,000,000 shares authorized; issued and outstanding: 2025—143,276,021 and 2024—144,952,026 143 145
Paid-in capital
Retained earnings 15,452 15,297
Accumulated other comprehensive loss -124 -152
Total shareholders’ equity 15,471 15,290
Total liabilities and shareholders’ equity $49,451 $49,359